Anas Hamad

480 total citations
56 papers, 263 citations indexed

About

Anas Hamad is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Anas Hamad has authored 56 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 15 papers in Oncology and 12 papers in Genetics. Recurrent topics in Anas Hamad's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Anas Hamad is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Anas Hamad collaborates with scholars based in Qatar, United Arab Emirates and Jordan. Anas Hamad's co-authors include Mohamed A. Yassin, Adel Elomri, Laoucine Kerbache, Dina Abushanab, Paul Wade, Cate Whittlesea, Gillian Cavell, Abdelfatteh El Omri, Mohamed Izham Mohamed Ibrahim and Abdulqadir J. Nashwan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Anas Hamad

46 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anas Hamad Qatar 11 69 50 50 40 31 56 263
Justin Arnall United States 12 75 1.1× 45 0.9× 10 0.2× 113 2.8× 53 1.7× 46 333
Andrea Belisari Italy 7 18 0.3× 112 2.2× 28 0.6× 40 1.0× 17 0.5× 23 462
Ewen Cameron United Kingdom 12 60 0.9× 35 0.7× 33 0.7× 6 0.1× 3 0.1× 30 660
Philippe Fagnoni France 11 61 0.9× 15 0.3× 14 0.3× 31 0.8× 7 0.2× 36 295
Boglárka Soós Hungary 10 28 0.4× 11 0.2× 5 0.1× 15 0.4× 13 0.4× 30 338
M. Thalheimer Germany 8 41 0.6× 18 0.4× 19 0.4× 180 4.5× 36 1.2× 18 374
Mike Gorenchtein United States 5 54 0.8× 35 0.7× 4 0.1× 25 0.6× 8 0.3× 11 427
Carole Chambers Canada 17 205 3.0× 127 2.5× 45 0.9× 40 1.0× 46 1.5× 58 677
Jim Siderov Australia 11 94 1.4× 86 1.7× 40 0.8× 3 0.1× 7 0.2× 37 372
Inga Bayh Germany 14 54 0.8× 7 0.1× 114 2.3× 75 1.9× 7 0.2× 22 568

Countries citing papers authored by Anas Hamad

Since Specialization
Citations

This map shows the geographic impact of Anas Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Hamad more than expected).

Fields of papers citing papers by Anas Hamad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Hamad. The network helps show where Anas Hamad may publish in the future.

Co-authorship network of co-authors of Anas Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Hamad. A scholar is included among the top collaborators of Anas Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Hamad. Anas Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chan, Esther W., et al.. (2024). Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis. Current Problems in Cancer. 50. 101076–101076. 1 indexed citations
3.
4.
Al‐Jedai, Ahmed, et al.. (2024). Expert Consensus Recommendations on a Biosimilars Value Framework for the Gulf Cooperation Council Countries. Therapeutic Innovation & Regulatory Science. 59(1). 153–163. 2 indexed citations
5.
Halat, Dalal Hammoudi, Ali Azeez Al‐Jumaili, Mohamad Rahal, et al.. (2024). Academic Entitlement Among Pharmacy Students in the Arab World: A Multi-National Exploratory Study. American Journal of Pharmaceutical Education. 88(2). 100640–100640. 4 indexed citations
6.
7.
Abushanab, Dina, et al.. (2023). Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital. Journal of Oncology Pharmacy Practice. 29(8). 1935–1943. 8 indexed citations
8.
Al‐Badriyeh, Daoud, et al.. (2023). Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar. Journal of Oncology Pharmacy Practice. 30(5). 792–801. 2 indexed citations
9.
Al‐Jumaili, Ali Azeez, et al.. (2023). Factors impacting job satisfaction among pharmacists in the Arab world: A qualitative study. Saudi Pharmaceutical Journal. 31(4). 578–584. 7 indexed citations
10.
Hamad, Anas, et al.. (2023). Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities. SHILAP Revista de lepidopterología. 6(4). 127–136. 1 indexed citations
11.
Elomri, Adel, et al.. (2022). Multi-Objective Simulation-Based Optimization for Effective Management of the Outpatient Chemotherapy Process. IFAC-PapersOnLine. 55(10). 1639–1644. 4 indexed citations
12.
Padmanabhan, Regina, Ishita Gupta, Nader Meskin, et al.. (2022). Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor. Frontiers in Oncology. 12. 977664–977664. 10 indexed citations
13.
Elomri, Adel, Laoucine Kerbache, Abdelfatteh El Omri, et al.. (2022). Bibliometric analysis of cancer care operations management: current status, developments, and future directions. Health Care Management Science. 25(1). 166–185. 16 indexed citations
14.
Yassin, Mohamed A., Ashraf Soliman, Omar Ismail, et al.. (2022). The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience. Cureus. 14(6). e25701–e25701. 3 indexed citations
15.
Alam, M Fasihul, et al.. (2022). Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation. International Journal of Environmental Research and Public Health. 20(1). 512–512. 4 indexed citations
16.
Abushouk, Abdelrahman Ibrahim, Ahmed E. Noreldin, Dina Johar, et al.. (2020). Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review. Frontiers in Immunology. 11. 1354–1354. 25 indexed citations
17.
Isleem, Ula, et al.. (2019). Shoulder girdle resection: surgical technique modification and introduction of a new classification system. World Journal of Surgical Oncology. 17(1). 107–107. 2 indexed citations
18.
Hail, Moza Al, et al.. (2018). Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar. International Journal of Clinical Pharmacy. 40(4). 769–774. 9 indexed citations
19.
Wilby, Kyle John, et al.. (2017). A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies. Drugs in R&D. 17(1). 73–78. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Arnall Breakdown of academic impact, for papers by Andrea Belisari Breakdown of academic impact, for papers by Ewen Cameron Breakdown of academic impact, for papers by Philippe Fagnoni Breakdown of academic impact, for papers by Boglárka Soós Breakdown of academic impact, for papers by M. Thalheimer Breakdown of academic impact, for papers by Mike Gorenchtein Breakdown of academic impact, for papers by Carole Chambers Breakdown of academic impact, for papers by Jim Siderov Breakdown of academic impact, for papers by Inga Bayh
Rankless by CCL
2026